The present invention relates to fluorophenyl substituted muscarinic receptor ligands with selectivity for M3 over M2 and to the use of these compounds in the treatment of various diseases such as asthma, chronic obstructive pulmonary disease (COPD), bronchopulmonary dysplasia (BPD) and urinary incontinence.
本发明涉及
氟苯基取代的毒蕈碱受体
配体,其对M3受体的选择性高于M2受体,并涉及这些化合物在治疗哮喘、慢性阻塞性肺病(
COPD)、支气管肺发育不良(BPD)和尿失禁等各种疾病中的用途。